IL13-PE38: Phase I/II

Preliminary results from 2 ongoing open-label U.S. Phase I/II trials of IL13-PE38 given

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE